Definition/General

Introduction:
-Cervical cervicitis is a general term for inflammation of the cervix involving both endocervical and ectocervical components
-It represents a broad category of inflammatory conditions affecting the entire cervical structure.
Origin:
-Results from various causes including infections (bacterial, viral, fungal), chemical irritants, mechanical trauma, autoimmune processes, and hormonal factors affecting cervical tissues.
Classification:
-WHO Classification categorizes as inflammatory cervical condition
-Classified as acute (neutrophil-predominant) or chronic (lymphoplasmacytic-predominant) based on duration and cellular infiltrate.
Epidemiology:
-Very common in reproductive-age women
-Affects up to 40% of sexually active women
-Associated with STIs, contraceptive use, and various environmental factors.

Clinical Features

Presentation:
-Variable presentation from asymptomatic to significant symptoms
-Common findings include abnormal vaginal discharge, cervical friability, and post-coital bleeding.
Symptoms:
-Mucopurulent vaginal discharge
-Post-coital bleeding
-Intermenstrual bleeding
-Pelvic pain or pressure
-Dysuria
-May be completely asymptomatic.
Risk Factors:
-Sexual activity
-STIs (Chlamydia, Gonorrhea, HSV, HPV)
-Multiple sexual partners
-Douching
-Contraceptive use
-Smoking
-Immunosuppression.
Screening:
-Routine pelvic examination
-Pap smear showing inflammatory changes
-STI testing
-Colposcopy if indicated
-Clinical assessment of discharge.

Master Cervical Cervicitis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Erythematous, edematous cervix with surface irregularity
-Mucopurulent discharge from cervical os
-Friable tissue with contact bleeding.
Characteristics:
-Variable appearance from mild erythema to severe inflammation
-Edematous, congested appearance
-Increased vascularity
-Friable consistency.
Size Location:
-May involve entire cervix or be localized to specific areas
-Commonly affects transformation zone
-Can extend to upper vagina.
Multifocality:
-Often diffuse involvement of cervical structures
-May have focal areas of more severe inflammation
-Bilateral involvement common.

Microscopic Description

Histological Features:
-Mixed inflammatory infiltrate in cervical stroma and epithelium
-Combination of acute and chronic inflammatory cells
-Reactive epithelial changes in both squamous and glandular components.
Cellular Characteristics:
-Lymphocytes, plasma cells, neutrophils, and histiocytes
-Reactive epithelial cells with enlarged nuclei
-Increased mitotic activity
-Squamous metaplasia common.
Architectural Patterns:
-Preserved overall architecture with inflammatory changes
-Surface erosions and ulcerations may be present
-Stromal edema and vascular congestion.
Grading Criteria:
-Benign inflammatory condition (no formal grading)
-Severity assessed as mild, moderate, or severe based on extent and intensity of inflammation.

Immunohistochemistry

Positive Markers:
-CD3 positive T-lymphocytes
-CD20 positive B-lymphocytes
-CD68 positive histiocytes/macrophages
-CD138 positive plasma cells.
Negative Markers:
-p16 variable (negative unless HPV-associated)
-High-risk HPV variable depending on etiology
-Neuroendocrine markers negative.
Diagnostic Utility:
-Primarily morphological diagnosis
-IHC may help characterize inflammatory cell populations
-p16 testing if HPV-related cervicitis suspected.
Molecular Subtypes:
-No specific molecular subtypes
-May be categorized by causative agent (infectious vs non-infectious) and inflammatory pattern.

Molecular/Genetic

Genetic Mutations:
-No specific genetic mutations
-Represents inflammatory response to various stimuli
-Normal cellular genetics with reactive changes only.
Molecular Markers:
-Elevated inflammatory cytokines (IL-1, IL-6, TNF-α)
-Increased chemokine expression
-NF-κB pathway activation
-Normal p53 expression.
Prognostic Significance:
-Generally excellent prognosis with appropriate treatment
-May increase risk of ascending infection
-Can affect fertility if severe and untreated.
Therapeutic Targets:
-Cause-specific therapy (antimicrobials for infections)
-Anti-inflammatory measures
-Removal of irritating factors
-Hormonal therapy if indicated.

Differential Diagnosis

Similar Entities:
-Cervical intraepithelial neoplasia
-Reactive epithelial atypia
-Cervical carcinoma
-Endometriosis
-Adenomyosis of cervix.
Distinguishing Features:
-Cervicitis: inflammatory infiltrate, preserved architecture
-CIN: dysplastic changes, p16 positive
-Carcinoma: malignant features, invasion.
Diagnostic Challenges:
-Distinction from reactive atypia
-Differentiation from early neoplastic processes
-Identification of specific causative agents.
Rare Variants:
-Granulomatous cervicitis
-Eosinophilic cervicitis
-Lymphocytic cervicitis
-Xanthogranulomatous cervicitis
-Follicular cervicitis.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Prognostic Factors

Prognostic factors: [list factors]

Final Diagnosis

Final diagnosis: [complete diagnosis]